Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity (2016)
- Authors:
- Machado Neto, João Agostinho
- Fenerich, Bruna Alves
- Scopim-Ribeiro, Renata
- Dechandt, Carlos Roberto Porto
- Alves, Ana Paula Nunes Rodrigues
- Fernandes, Jaqueline Cristina
- Scheucher, Priscila Santos
- Simões, Belinda Pinto
- Alberici, Luciane Carla
- Pontes, Lorena Lôbo de Figueiredo
- Rego, Eduardo Magalhães
- Traina, Fabiola
- Machado Neto, João Agostinho
- USP affiliated authors: SIMOES, BELINDA PINTO - FMRP ; REGO, EDUARDO MAGALHÃES - FMRP ; TRAINA, FABÍOLA - FMRP ; SCHEUCHER, PRISCILA SANTOS - FMRP ; ALBERICI, LUCIANE CARLA - FCFRP
- Unidades: FMRP; FCFRP
- Subjects: CLÍNICA GERAL; LEUCEMIA MIELOIDE; INSULINA
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Annual Meeting and Exposition of the American Society of Hematology
-
ABNT
MACHADO NETO, João Agostinho et al. Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity. 2016, Anais.. San Diego: ASH, 2016. Disponível em: http://www.bloodjournal.org/content/128/22/1960. Acesso em: 28 dez. 2025. -
APA
Machado Neto, J. A., Fenerich, B. A., Scopim-Ribeiro, R., Dechandt, C. R. P., Alves, A. P. N. R., Fernandes, J. C., et al. (2016). Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity. In Abstracts. San Diego: ASH. Recuperado de http://www.bloodjournal.org/content/128/22/1960 -
NLM
Machado Neto JA, Fenerich BA, Scopim-Ribeiro R, Dechandt CRP, Alves APNR, Fernandes JC, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Rego EM, Traina F. Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity [Internet]. Abstracts. 2016 ;[citado 2025 dez. 28 ] Available from: http://www.bloodjournal.org/content/128/22/1960 -
Vancouver
Machado Neto JA, Fenerich BA, Scopim-Ribeiro R, Dechandt CRP, Alves APNR, Fernandes JC, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Rego EM, Traina F. Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity [Internet]. Abstracts. 2016 ;[citado 2025 dez. 28 ] Available from: http://www.bloodjournal.org/content/128/22/1960 - Reversine triggers mitotic catastrophe and apoptosis in K562 cells
- Pharmacological IGF1R/IRS inhibitor, NT157, effectively induces apoptosis and CDKN1A expression in acute lymphoblastic leukemia cells
- Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms
- Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells
- Reversine triggers mitotic catastrophe and apoptosis in BCR-ABL positive cells
- Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells
- Activation of IRS1/beta-catenin axis in acute lymphoblastic leukemia
- IRS1/β-catenin axis is activated and induces MYC expression in acute lymphoblastic leukemia cells
- A inibição farmacológica de IRS1/2 induz apoptose em células BCR-ABL1 T315I
- Aplicação integrada de critérios clínicos, citogenéticos e moleculares na estratificação de risco em pacientes com leucemia mieloide aguda em laboratório de referência em um estudo multicêntrico brasileiro
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
